semaglutide push health compounded Novo Nordisk calls out dangers of GLP-1s in new ad Hims & Hers offers compounded Higher-dose obesity medication wins FDA

Retatrutides trial results are impressive which is exactly why interest is so high, and exactly why people are being offered it before it has completed the regulatory process that Mounjaro and Wegovy have already been through

The absorption and effectiveness of Rybelsus can be impacted if not taken properly

If a platforms policies on patient privacy arent easy to find and understand, consider it a red flag

Nat Rev Cardiol 2018

While both medications can support weight loss, the amount of weight lost and the timeline can vary based on dosage, lifestyle habits, and individual metabolism

Key takeaways Low-dose IGF-1 LR3 infusion did not improve beta cell growth or function in models of fetal growth restriction (FGR) caused by placental insufficiency